Revvity | PKI - Дебиторская задолженность





Дебиторская задолженность Изменить Дата
Agilent USD 1.5B 23M 2026-03
Align Technology USD 1.13B 23.36M 2026-03
Bio Techne USD 214.56M 29.95M 2026-03
Bio-Rad Laboratories USD 460.6M 4.1M 2025-12
Bruker USD 542.7M 2.2M 2026-03
Celltrion KRW 2.05T 542.39B 2025-12
Charles River Laboratories USD 700.25M 727.92M 2026-03
Cspc Pharmaceutical CNY 8.79B 64.64M 2025-12
Danaher USD 4.76B 845M 2026-03
Dentsply International USD 622M 66M 2026-03
Deva Holding AS TRY 3.03B 343.23M 2023-09
Dianthus Therapeutics USD 1.23M 1.18M 2026-03
Divis Laboratories Ltd INR 29.99B 3.71B 2026-03
Edwards Lifesciences USD 912.1M 19.3M 2025-12
Illumina USD 738M 116M 2026-03
Intuitive Surgical USD 1.6B 68.3M 2026-03
IQVIA Holdings USD 3.38B 52M 2026-03
Kangmei Pharma CNY 2.92B 228.09M 2026-03
Knight Therapeutics CAD 183M 7.46M 2025-12
Laboratorios Farma EUR 143.38M 16.93M 2023-12
Laboratory Of America USD 2.45B 189.8M 2026-03
Malin Corporation EUR 500K 300K 2024-12
Medical Developments International AUD 7.48M 174K 2025-12
Mesa Laboratories USD 40.23M 4.66M 2024-09
Mettler Toledo International USD 708.21M 70.04M 2026-03
Myriad Genetics USD 115.3M 2.7M 2025-12
Neuren Pharmaceuticals AUD 26.54M 5.83M 2025-12
OraSure Technologies USD 22.2M 2.1M 2025-12
Organigram Holdings CAD 53.39M 3.45M 2026-03
Ovoca Bio EUR 39K 408K 2025-06
Pacific Biosciences Of California USD 35.45M 4.83M 2025-12
Pharma Mar EUR 51.19M 9.4M 2026-03
Qiagen NV USD 402.61M 9.05M 2025-12
Quest Diagnostics USD 1.59B 179M 2026-03
Quidel USD 359.9M 57.1M 2026-03
Repligen USD 151.55M 7.03M 2026-03
Revvity USD 691.38M 53.29M 2026-03
Sartorius EUR 366.6M 74.9M 2026-03
Sino Biopharmaceutical CNY 8.45B 3.18B 2025-06
Thermo Fisher Scientific USD 9.2B 304M 2026-03
Tilray USD 109.07M 2M 2025-09
Waters USD 1.76B 930.16M 2026-03
Zealand Pharma A/S 340M 94.1M 2025-12
Zz Pientze Pharmaceu CNY 1.06B 60.42M 2026-03